Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03000023 · ClinicalTrials.gov registry record
Anticipated and Perceived Benefits Following Hepatitis C Treatment
A clinical trial of Hepatitis C and Hepatitis C, Chronic, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT03000023: Completed study of Hepatitis C and Hepatitis C, Chronic, sponsored by University of North Carolina, Chapel Hill.
NCT03000023 is a study of Hepatitis C and Hepatitis C, Chronic that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 100 participants, below the 1,889-participant average among 106 other Hepatitis C trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03000023, a study of Hepatitis C and Hepatitis C, Chronic, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is both qualitative and quantitative, gathering patient's perceptions of HCV treatment benefits before and after HCV treatment by administering surveys and conducting in-depth qualitative patient interviews. The study seeks to understand all anticipated and actual benefits patients perceive before and after viral eradication.
Primary Outcome
To conduct a pre-post qualitative analysis that will evaluate changes in a broad range of patients' perceptions of psychological, social, and physical effects associated with HCV and viral cure collected through qualitative interviews.
Conditions Studied
Study Locations (1)
North Carolina
- University of North Carolina - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2016-10 |
| Est. Completion | 2018-07 |
What the finished NCT03000023 record still lists
NCT03000023 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,889-participant average among 106 other Hepatitis C trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Hepatitis C appearing as the primary indexed condition, and to 0 interventions.
NCT03000023 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03000023 about?
NCT03000023 is a clinical study titled "Anticipated and Perceived Benefits Following Hepatitis C Treatment". The study is both qualitative and quantitative, gathering patient's perceptions of HCV treatment benefits before and after HCV treatment by administering surveys and conducting in-depth qualitative patient interviews. The study seeks to understand all anticipated and actual benefits patients perceiv...
What is the current status of trial NCT03000023?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2016-10. Estimated completion is 2018-07.
What conditions does trial NCT03000023 study?
This clinical trial studies the following conditions: Hepatitis C, Hepatitis C, Chronic.
Who is sponsoring clinical trial NCT03000023?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03000023 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis C
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03000023's enrollment target sits among peer trials
100 56th of 106 higher than 49 of 106 other Hepatitis C trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hepatitis C trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
RECRUITING · NA
-
Evaluation of Patients With Liver Disease
RECRUITING
-
The HOPE Study: Characterizing Patients With Hepatitis B and C
RECRUITING
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
RECRUITING · NA
-
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia